Back
Also listed as
MEOBF
OTC
Day Range
$14.02
$14.87
52-Week Range
$9.61
$21.50
Volume
1,227,836
50D / 200D Avg
$16.77
/
$15.78
Prev Close
$14.36
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -17.7 | 0.4 |
| P/B | 3.0 | 2.9 |
| ROE % | -19.0 | 3.8 |
| Net Margin % | -593.9 | 3.9 |
| Rev Growth 5Y % | 23.2 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue grew 23.24% annually over 5 years — strong growth
Debt/Equity of 0.21 — conservative balance sheet
Negative free cash flow of -50.68M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 168.15%
Capital efficient — spends only 4.24% of revenue on capex
Growth
Revenue Growth (5Y)
23.24%
Revenue (1Y)191.39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-18.95%
ROIC-6.45%
Net Margin-593.92%
Op. Margin-363.08%
Safety
Debt / Equity
0.21
Current Ratio1.99
Interest Coverage-2.72
Valuation
P/E Ratio
-17.66
P/B Ratio3.02
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 191.39% | Revenue Growth (3Y) | 51.42% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23.24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 17.20M | Net Income (TTM) | -102.14M |
| ROE | -18.95% | ROA | -13.02% |
| Gross Margin | 70.17% | Operating Margin | -363.08% |
| Net Margin | -593.92% | Free Cash Flow (TTM) | -50.68M |
| ROIC | -6.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.21 | Current Ratio | 1.99 |
| Interest Coverage | -2.72 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -17.66 | P/B Ratio | 3.02 |
| P/S Ratio | 104.91 | PEG Ratio | 2.44 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.80B | Enterprise Value | 1.77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.20M | 5.90M | 7.50M | 10.21M | 7.46M |
| Net Income | -102.14M | -87.96M | -81.89M | -91.35M | -98.81M |
| EPS (Diluted) | -0.84 | -0.89 | -0.98 | -1.30 | -1.60 |
| Gross Profit | 12.07M | -35.17M | -47.42M | -53.36M | -78.28M |
| Operating Income | -62.44M | -84.15M | -69.29M | -80.57M | -109.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 784.68M | 669.15M | 669.42M | 662.14M | 744.72M |
| Total Liabilities | 187.24M | 188.80M | 167.58M | 165.10M | 163.32M |
| Shareholders' Equity | 597.44M | 480.36M | 501.84M | 497.04M | 581.40M |
| Total Debt | 128.16M | 118.92M | 116.50M | 106.91M | 105.50M |
| Cash & Equivalents | 161.16M | 62.56M | 70.92M | 60.03M | 136.88M |
| Current Assets | 204.35M | 86.46M | 81.66M | 69.84M | 148.23M |
| Current Liabilities | 102.63M | 73.24M | 41.98M | 51.37M | 94.27M |